21 September 2022
Spanish Group for Cancer Immuno-Biotherapy (GÉTICA) Is Now an Affiliated Society Member of the Journal of Clinical Medicine
In September 2022, the Spanish Group for Cancer Immuno-Biotherapy (GÉTICA) chose the Journal of Clinical Medicine (ISSN: ISSN 2077-0383) as its preferred journal and became an affiliated society member. As part of this collaboration, all members of GÉTICA will benefit from a discount on the article processing charge (APC) when submitting articles to the Journal of Clinical Medicine.
GÉTICA is a Spanish non-profit association that was established in 2014 by and for clinicians as well as scientists in basic and/or translational research who are interested in tumor immunology and immunotherapies for cancer treatment. The overarching aims of GÉTICA are as follows:
1) to advance the research on and development of novel immunotherapies;
2) to promote the education of researchers and clinicians in these fields;
3) to foster public engagement by communicating the latest developments in cancer immunology and immunotherapy.
A further priority is to integrate other scientific societies and cooperative groups with GÉTICA, in order to establish a strong multidisciplinary and collaborative scientific environment that will help us to drive the field of cancer immunology forward and further the development of novel immunotherapies.
The Spanish Group for Cancer Immuno-Biotherapy (GÉTICA) is a professional organization whose functions are highly relevant to the scope of the Journal of Clinical Medicine.
We look forward to collaborating with GÉTICA and publishing state-of-the-art research from its members in this field.
